Systematic review of 31 studies (24 meta-analysed) in advanced EGFR-mutated NSCLC: adding local ablative therapy to first-line EGFR TKI was associated with better PFS (HR 0.45) and OS (HR 0.52); pneumonitis was more frequent but grade 3+ events uncommon.
Meta-analysisn = 31 studies
Brunetti et al. First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis